nach oben

International Journal of Behavioral Medicine

Erschienen in:

01.02.2014

Managing Uncertainty: Healthcare Professionals' Meanings Regarding the HPV Vaccine

verfasst von: Irina Todorova, Anna Alexandrova-Karamanova, Yulia Panayotova, Elitsa Dimitrova, Tatyana Kotzeva

Erschienen in: International Journal of Behavioral Medicine | Ausgabe 1/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

New preventive technologies such as vaccines offer insight into psychological, social, and cultural landscapes. Providers have a key role in parents' decisions for vaccinating their children. Yet, perspectives from providers regarding the human papillomavirus (HPV) vaccine, or vaccination in general, are rarely sought

Purpose

Our objective in this paper is to understand how the HPV vaccine is perceived by health care providers and the multiple contextual meanings it elicits.

Methods

We conducted interviews with 20 health care professionals in Bulgaria about their attitudes and practices related to HPV vaccination and their recommendations for policies. The verbatim-transcribed interviews were analyzed through narrative analysis, with a special focus on language.

Results

We illustrate providers' contradictory and contextualized constructions of the vaccine and the narrative strategies they use to manage any uncertainty it elicits. These include being advocates and missionaries for preventive health, confirming their trust in the medical profession and professional organizations, challenging patients' concerns with rational explanations, normalizing the risk of medical innovations, and avoiding the sexual nature of HPV transmission.

Conclusions

The introduction of a vaccine to prevent HPV infection, and by implication, possibly cervical and other cancers, created hope, and at the same time, intensified confusion and uncertainty. Providers have been frustrated for years with the rising mortality from cervical cancer in Bulgaria, and their perceived powerlessness in affecting this. HPV vaccination, on the other hand, seems relatively simple and “taming uncertainty” positions them as instrumental in limiting (or even eliminating) morbidity and mortality in future generations.

Transmission is also possible through skin-to-skin contact and from mother to child during birth.

Though there are hundreds of types of HPV virus, the vaccines target only those types that are responsible for over 75 % of all cancers. In general, the HPV virus is very widespread, with 80 % of the population considered to have it at some point in their lives. In most cases, the infection disappears on its own without any consequences, but in some cases, it is persistent and can lead to cancerous changes many years later.

The rubella vaccine was first introduced for girls and later added for boys.

I = Interviewer; P = Participant

Wailoo K, Livingston J, Aronowitz R. Vaccine time lines. In: Wailoo K, Livingston J, Aronowitz R, editors. Three shots at prevention: the HPV vaccine and the politics of medicine's simple solutions. Baltimore: Johns Hopkins University Press; 2010. p. xix–xxix.

Barroso LF, Wilkin T. Human papillomavirus vaccination in males: the state of the science. Curr Infect Dis Rep. 2011;13(2):175–81. doi:10.1007/s11908-010-0163-7.PubMedCrossRef

European Centre for Disease Prevention and Control. Guidance for the introduction of HPV vaccines in EU countries. 2008.

King LA, Lévy-Bruhl D, O’Flanagan D, Bacci S, Lopalco PL, Kudjawu Y, et al. Introduction of human papillomavirus (HPV) vaccination into national immunization schedules in Europe: results of the VENICE 2007 survey. Eurosurveillance. 2008;13(7–9):1–6.

American Academy of Pediatrics. HPV vaccine recommendations. Pediatrics. 2012;129(3):602–5.CrossRef

Gottlieb SD. Manufactured uncertainty: the human papillomavirus (HPV) vaccine and the object multiple. US: ProQuest Information & Learning; 2011.

Newmann SJ, Garner EO. Social inequities along the cervical cancer continuum: a structured review. Cancer Causes and Control. 2005;16:63–70.PubMedCrossRef

Tomljenovic L, Shaw CA. Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? Ann Med. 2013;45(2):182–93.PubMedCrossRef

Braun L, Phoun L. HPV vaccination campaigns: masking uncertainty, erasing complexity. In: Wailoo K, Livingston J, Epstein S, Aronowitz R, editors. Three shots at prevention: The HPV vaccine and the politics of medicine's simple solutions. Baltimore: Johns Hopkins University; 2010.

10.

Tsu VD, Levin CE. Making the case for cervical cancer prevention: what about equity? Reprod Health Matters. 2008;16(32):104–16.PubMedCrossRef

11.

Farmer P. Dimensions of health disparities in infectious diseases: Key Note lecture. Centers for Population Health and Health Disparities Annual Meeting; May 1–2; Boston, MA2013.

12.

Julius JM, Ramondeta L, Tipton KA, Lal LS, Schneider K, Smith JA. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer. Pharmacotherapy. 2011;31(3):280–97.PubMedCrossRef

13.

Casper MJ, Carpenter LM. Sex, drugs, and politics: the HPV vaccine for cervical cancer. Sociol Health Illn. 2008;30(6):886–9.PubMedCrossRef

14.

Charo RA. Politics, parents, and prophylaxis—mandating HPV vaccination in the United States. N Engl J Med. 2007;356(19):1905–8.PubMedCrossRef

15.

Javitt G, Berkowitz D, Gostin LO. Assessing mandatory HPV vaccination: who should call the shots? J Law Med Ethics. 2008;36(2):384.PubMedCrossRef

16.

Gakidou E, Nordhagen S, Obermeyer Z. Coverage of cervical cancer screening in 57 countries: low-average levels and large inequalities. PLOSMedicine. 2008;5(6):e132.

17.

Huang CM. Human papillomavirus and vaccination. Mayo Clinic Proceedings. 2008;83(6):701.PubMed

18.

Avramova L, Alexandrova A, Balabanova D, Bradley J, Panayotova Y, Todorova I. Cervical cancer screening in Bulgaria: psychosocial aspects and health systems dimensions. Sofia, Bulgaria: Health Psychology Research Center & EngenderHealth; 2005.

19.

Todorova I, Baban A, Alexandrova-Karamanova A, Bradley J. Inequalities in cervical cancer screening in Eastern Europe: perspectives from Bulgaria and Romania. Int J Public Health. 2009;54:222–32.PubMedCrossRef

20.

Bonanni P, Levi M, Latham NB, Bechini A, Tiscione E, Lai P, et al. An overview on the implementation of HPV vaccination in Europe. Hum Vaccin. 2011;7(Suppl):128–35.PubMedCrossRef

21.

Ministry of Health. Национална програма за първична профилактика на маточната шийка в България 2012–2016. (National program for primary prevention of cervical cancer in Bulgaria 2012–2016). Sofia, Bulgaria: Voted by Council of Ministers, Protokol #25, June 25th 2012.

22.

Bartlett JA, Peterson JA. The uptake of human papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. J Sch Nurs. 2011;27(6):434–46.PubMedCrossRef

23.

Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med. 2007;45(2–3):107–14. doi:10.1016/j.ypmed.2007.05.013.PubMedCrossRef

24.

Brewer NT, Gottlieb SL, Reiter PL, McRee A-L, Liddon N, Markowitz L, et al. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis. 2011;38(3):197–204. doi:10.1097/OLQ.0b013e3181f12dbf.PubMedCentralPubMedCrossRef

25.

Dimitrova E, Panayotova Y, Alexandrova-Karamanova A, Todorova I. Doctors' and parents' perspectives on communication regarding HPV vaccination in Bulgaria. Health, Culture and the Human Body; 15–17 September 2012; Istanbul, Turkey2012.

26.

Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30(24):3546–56.PubMedCrossRef

27.

Trim K, Nagji N, Elit L, Roy K. Parental knowledge, attitudes, and behaviours towards human papillomavirus vaccination for their children: a systematic review from 2001 to 2011. Obstet Gynecol Int. 2012;2012:1–12. doi:10.1155/2012/921236.CrossRef

28.

Brownlie J, Howson A. 'Between the demands of truth and government': health practitioners, trust and immunisation work. Soc Sci Med. 2006;62(2):433–43. doi:10.1016/j.socscimed.2005.05.033.PubMedCrossRef

29.

Barnack JL, Reddy DM, Swain C. Predictors of parents' willingness to vaccinate for human papillomavirus and physicians' intentions to recommend the vaccine. Women's Health Issues. 2010;20(1):28–34.PubMedCrossRef

30.

Huey NL, Clark AD, Kluhsman BC, Lengerich EJ. HPV vaccine attitudes and practices among primary care providers in Appalachian Pennsylvania. Prev Chronic Dis. 2009;6(2):A49.PubMedCentralPubMed

31.

Ko EM, Missmer S, Johnson NR. Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis. 2010;14(4):339–45.PubMedCrossRef

32.

Lutringer-Magnin D, Kalecinski J, Barone G, Leocmach Y, Regnier V, Jacquard AC, et al. Human papillomavirus (HPV) vaccination: perception and practice among French general practitioners in the year since licensing. Vaccine. 2011;29(32):5322–8.PubMedCrossRef

33.

Songthap A, Pitisuttithum P, Kaewkungwal J, Fungladda W, Bussaratid V, Koonsaeng S. Knowledge, attitudes, and acceptability of a human papillomavirus vaccine among healthcare providers. Southeast Asian J Trop Med Public Health. 2009;40(5):1048–56.PubMed

34.

Weiss TW, Zimet GD, Rosenthal SL, Brenneman SK, Klein JD. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health. 2010;47(1):3–11. doi:10.1016/j.jadohealth.2010.03.003.PubMedCrossRef

35.

Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, et al. Provider perceptions of barriers and facilitators of HPV vaccination in a high-risk community. Vaccine. 2012;30(30):4511–6.PubMedCrossRef

36.

Cranley L, Doran DM, Tourangeau AE, Kushniruk A, Nagle L. Nurses' uncertainty in decision-making: a literature review. Worldviews Evid Based Nurs. 2009;6(1):3–15. doi:10.1111/j.1741-6787.2008.00138.x.PubMedCrossRef

37.

O'Riordan M, Aktürk Z, Ortiz JMB, Dağdeviren N, Elwyn G, Micallef A, et al. Dealing with uncertainty in general practice: an essential skill for the general practitioner. Qual Prim Care. 2011;19(3):175–81.PubMed

38.

Shapiro J, Astin J, Shapiro SL, Robitshek D, Shapiro DH. Coping with loss of control in the practice of medicine. Fam Syst Health. 2011;29(1):15–28. doi:10.1037/a0022921.PubMedCrossRef

39.

Breaden K, Hegarty M, Swetenham K, Grbich C. Negotiating uncertain terrain: a qualitative analysis of clinicians' experiences of refractory suffering. J Palliat Med. 2012;15(8):896–901. doi:10.1089/jpm.2011.0442.PubMedCrossRef

40.

Holmes S, Ponte M. En-case-ing the patient: disciplining uncertainty in medical student patient presentations. Cult Med Psychiatry. 2011;35(2):163–82. doi:10.1007/s11013-011-9213-3.PubMedCrossRef

41.

Nevalainen MK, Mantyranta T, Pitkala KH. Facing uncertainty as a medical student—a qualitative study of their reflective learning diaries and writings on specific themes during the first clinical year. Patient Educ Couns. 2010;78(2):218–23. doi:10.1016/j.pec.2009.07.011.PubMedCrossRef

42.

Riessman CK. Performing identities in illness narrative: masculinity and multiple sclerosis. Qual Res. 2003;3(1):5–33.CrossRef

43.

Stephens C. Narrative analysis in health psychology research: personal, dialogical and social stories of health. Health Psychol Rev. 2011;5(1):62–78.CrossRef

44.

Lupton D. The imperative of health: Public health and the regulated body. Thousand Oaks: Sage; 1995.

45.

Gold K. Reading (and writing) between the lines: Narrative as relational resource for alternative stories of health care practice. Tilburg: Tilburg University; 2013.

46.

Todorova I, Baban A, Balbanova D, Panayotova Y, Bradley J. Providers' construction of women's role in cervical cancer screening in Eastern Europe. Soc Sci Med. 2006;63(3):776–87.PubMedCrossRef

47.

Todorova I. Preventing cancer in men and women: Current advances, disparities, contexts and examples from HPV related cancers. Key Note Lecture. 13th International Congress of Behavioral Medicine; Budapest, Hungary2012.

Titel: Managing Uncertainty: Healthcare Professionals' Meanings Regarding the HPV Vaccine
verfasst von: Irina Todorova
Anna Alexandrova-Karamanova
Yulia Panayotova
Elitsa Dimitrova
Tatyana Kotzeva
Publikationsdatum: 01.02.2014
Verlag: Springer US
Erschienen in: International Journal of Behavioral Medicine / Ausgabe 1/2014
Print ISSN: 1070-5503
Elektronische ISSN: 1532-7558
DOI: https://doi.org/10.1007/s12529-013-9343-9

Springer Medizin

Abstract

Background

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2014

Workplace Psychosocial Factors Associated with Work-Related Injury Absence: A Study from a Nationally Representative Sample of Korean Workers

Keeping the ‘Goose’ on the Menu: Response to Commentaries on Financial Incentives in Health Behaviour Change

Psychological Resources as Mediators of the Association Between Social Class and Health: Comparative Findings from Japan and the USA

Young Women's Constructions of the HPV Vaccine: A Cross-Cultural, Qualitative Study in Scotland, Spain, Serbia and Bulgaria

Social Integration, Socioeconomic Conditions and Type of Ill Health Preceding Disability Pension in Young Women: a Swedish Population-Based Study

Perceived Sufficiency of Physical Activity Levels Among Adults at High Risk of Type 2 Diabetes: The FIN-D2D Study